{"groups":[{"description":"Gardasil (quadrivalent HPV types 6, 11, 16, 18) vaccination at weeks 0, 8, 24.\n\nquadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine\n\nlaboratory biomarker analysis","id":"FG000","title":"Vaccination"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"24"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"3"}],"type":"Relocated"},{"reasons":[{"groupId":"FG000","numSubjects":"8"}],"type":"Refusal after starting therapy"},{"reasons":[{"groupId":"FG000","numSubjects":"4"}],"type":"Protocol Violation"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Refusal prior to therapy"},{"reasons":[{"groupId":"FG000","numSubjects":"2"}],"type":"Incarceration"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"149"}],"comment":"Enrolled","type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"145"}],"type":"Eligible"},{"achievements":[{"groupId":"FG000","numSubjects":"144"}],"type":"Received First Vaccine Injection"},{"achievements":[{"groupId":"FG000","numSubjects":"141"}],"type":"Received Second Vaccine Injection"},{"achievements":[{"groupId":"FG000","numSubjects":"138"}],"type":"Received Third Vaccine Infjection"},{"achievements":[{"groupId":"FG000","numSubjects":"124"}],"type":"Returned After Week 28"},{"achievements":[{"groupId":"FG000","numSubjects":"106"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"43"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}